| 000 | 01856 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514194824.0 | ||
| 264 | 0 | _c20040909 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0002-953X | ||
| 024 | 7 |
_a10.1176/appi.ajp.161.8.1494 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBourgeois, Marc | |
| 245 | 0 | 0 |
_aAwareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial. _h[electronic resource] |
| 260 |
_bThe American journal of psychiatry _cAug 2004 |
||
| 300 |
_a1494-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAwareness |
| 650 | 0 | 4 |
_aBenzodiazepines _xtherapeutic use |
| 650 | 0 | 4 |
_aClozapine _xtherapeutic use |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aDepressive Disorder _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Status |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSchizophrenia _xdiagnosis |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 650 | 0 | 4 |
_aSuicide _xpsychology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aSuicide Prevention |
| 700 | 1 | _aSwendsen, Joel | |
| 700 | 1 | _aYoung, Frederick | |
| 700 | 1 | _aAmador, Xavier | |
| 700 | 1 | _aPini, Stefano | |
| 700 | 1 | _aCassano, Giovanni B | |
| 700 | 1 | _aLindenmayer, Jean-Pierre | |
| 700 | 1 | _aHsu, Chuanchieh | |
| 700 | 1 | _aAlphs, Larry | |
| 700 | 1 | _aMeltzer, Herbert Y | |
| 773 | 0 |
_tThe American journal of psychiatry _gvol. 161 _gno. 8 _gp. 1494-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1176/appi.ajp.161.8.1494 _zAvailable from publisher's website |
| 999 |
_c14987158 _d14987158 |
||